Get started
ZAI LAB LIMITEDZAI LAB LIMITEDZAI LAB LIMITED

ZAI LAB LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

9688 chart


Full chart

9688 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪22.33 B‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.15 HKD
Net income (FY)
‪−2.62 B‬ HKD
Revenue (FY)
‪2.09 B‬ HKD
Shares float
‪920.45 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
‪2.17 K‬
Change (1Y)
+139 +6.83%
Revenue / Employee (1Y)
‪960.06 K‬ HKD
Net income / Employee (1Y)
‪−1.20 M‬ HKD

About ZAI LAB LIMITED


Sector
Health Technology
Industry
Biotechnology
CEO
Ying Du
Website
zailaboratory.com
Headquarters
Shanghai
Founded
2014
FIGI
BBG00XDH4HP6
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

9688 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 9688 is 21.15 HKD — it has increased by 2.70% in the past 24 hours. Watch ZAI LAB LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ZAI LAB LIMITED stocks are traded under the ticker 9688.
9688 stock has fallen by −4.77% compared to the previous week, the month change is a −2.78% fall, over the last year ZAI LAB LIMITED has showed a −8.24% decrease.
We've gathered analysts' opinions on ZAI LAB LIMITED future price: according to them, 9688 price has a max estimate of 56.01 HKD and a min estimate of 15.00 HKD. Watch 9688 chart and read a more detailed ZAI LAB LIMITED stock forecast: see what analysts think of ZAI LAB LIMITED and suggest that you do with its stocks.
9688 reached its all-time high on Jan 21, 2021 with the price of 151.20 HKD, and its all-time low was 10.55 HKD and was reached on Apr 19, 2024. View more price dynamics on 9688 chart.
See other stocks reaching their highest and lowest prices.
9688 stock is 5.10% volatile and has beta coefficient of 1.05. Track ZAI LAB LIMITED stock price on the chart and check out the list of the most volatile stocks — is ZAI LAB LIMITED there?
Today ZAI LAB LIMITED has the market capitalization of ‪22.44 B‬, it has decreased by −1.14% over the last week.
Yes, you can track ZAI LAB LIMITED financials in yearly and quarterly reports right on TradingView.
ZAI LAB LIMITED is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
9688 earnings for the last quarter are −0.03 HKD per share, whereas the estimation was −0.62 HKD resulting in a 94.97% surprise. The estimated earnings for the next quarter are −0.55 HKD per share. See more details about ZAI LAB LIMITED earnings.
ZAI LAB LIMITED revenue for the last quarter amounts to ‪795.51 M‬ HKD, despite the estimated figure of ‪789.91 M‬ HKD. In the next quarter, revenue is expected to reach ‪838.43 M‬ HKD.
9688 net income for the last quarter is ‪−325.01 M‬ HKD, while the quarter before that showed ‪−627.59 M‬ HKD of net income which accounts for 48.21% change. Track more ZAI LAB LIMITED financial stats to get the full picture.
No, 9688 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has ‪2.17 K‬ employees. See our rating of the largest employees — is ZAI LAB LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZAI LAB LIMITED EBITDA is ‪−2.49 B‬ HKD, and current EBITDA margin is −134.54%. See more stats in ZAI LAB LIMITED financial statements.
Like other stocks, 9688 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZAI LAB LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZAI LAB LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZAI LAB LIMITED stock shows the sell signal. See more of ZAI LAB LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.